Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

RMD

Resmed

NYSE

Real-time Quotes | Nasdaq Last Sale

190.21

-3.00

-1.55%

After Hours: 190.20 -0.01 -0.01% 19:01 03/03 EST

OPEN

191.80

PREV CLOSE

193.21

HIGH

191.80

LOW

188.47

VOLUME

386.22K

TURNOVER

52 WEEK HIGH

224.43

52 WEEK LOW

108.85

MARKET CAP

27.68B

P/E (TTM)

39.76

News

Financial

Releases

Corp Actions

Analysis

Profile

Sleep Apnea Monitoring Instruments Market 2021 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, and Key Country Forecast to 2026

Mar 03, 2021 (The Expresswire) -- Global “Sleep Apnea Monitoring Instruments Market” (2021-2026) to its vast repository and growth prospects of the market...

The Express Wire · 8h ago

Sleep Diagnostic Devices Market Size, Growth, Share 2021, Segmentation and by Recent Trends, Development and by Regions to 2026

Mar 03, 2021 (The Expresswire) -- Global Sleep Diagnostic Devices Market 2021 industry research report gives Advancement strategies and plans are talked...

The Express Wire · 17h ago

ResMed Inc. stock falls Tuesday, underperforms market

Shares of ResMed Inc. shed 1.23% to $193.21 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...

marketwatch.com · 1d ago

Adult Ventilators Market Strategies and Insight Driven Transformation 2021-2030 | Koninklijke Philips N.V, Drgerwerk AG & Co.

Mar 01, 2021 (WiredRelease via Comtex) -- A consciously conceived and designed business intelligence report titled Global Adult Ventilators market 2021 by...

marketresearch.biz · 2d ago

Why Is ResMed (RMD) Down 10.7% Since Last Earnings Report?

Zacks.com · 4d ago

Why Is ResMed (RMD) Down 10.7% Since Last Earnings Report?

Zacks.com · 4d ago

ResMed Inc. stock falls Friday, underperforms market

Shares of ResMed Inc. shed 1.13% to $192.78 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...

marketwatch.com · 5d ago

Global Portable Respiratory Monitor Market Research Report 2020-2026

Feb 26, 2021 (Heraldkeepers) -- The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes...

Heraldkeepers · 5d ago

Forecast

EPSBVPSCFPS

Actual (USD)

Estimate (USD)

Income StatementMore

Net IncomeTotal RevenueOperating Income

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

OperatingInvestingFinancing

Operating (USD)

YoY (%)

Learn about the latest financial forecast of RMD. Analyze the recent business situations of Resmed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RMD stock price target is 214.60 with a high estimate of 241.00 and a low estimate of 165.00.

EPS

Institutional Holdings

Institutions: 897

Institutional Holdings: 106.59M

% Owned: 73.25%

Shares Outstanding: 145.51M

TypeInstitutionsShares

Increased

234

3.28M

New

162

917.91K

Decreased

224

3.65M

Sold Out

Performance
Asset Allocation
Dividend History

No Data

Industry

Advanced Medical Equipment & Technology

-2.96%

Healthcare Equipment & Supplies

-2.63%

Key Executives

Non-Executive Chairman

Peter Farrell

President/Chief Operating Officer

Rob Douglas

President/Chief Operating Officer

Robert Douglas

Chief Executive Officer/Director

Michael Farrell

Chief Financial Officer

Brett Sandercock

Corporate Executive

Jim Hollingshead

Corporate Executive

Justin Leong

Corporate Executive

Raj Sodhi

Corporate Executive

Rajwant Sodhi

Chief Administrative Officer/General Counsel/Secretary

David Pendarvis

Lead Director/Independent Director

Ronald Taylor

Independent Director

Carol Burt

Independent Director

Jan De Witte

Independent Director

Karen Drexler

Independent Director

Harjit Gill

Independent Director

Richard Sulpizio

Dividends
Splits
Insider Activity

Declaration Date Dividend Per Share Ex-Div Date: 01/28/2021
Dividend USD 0.39
02/10/2021; 10/29/2020
Dividend USD 0.39
11/10/2020; 08/05/2020
Dividend USD 0.39
08/19/2020; 04/30/2020
Dividend USD 0.39
05/13/2020; 01/30/2020
Dividend USD 0.39
02/12/2020; 10/24/2019
Dividend USD 0.39
11/06/2019; 07/25/2019
Dividend USD 0.39
08/14/2019; 05/02/2019
Dividend USD 0.37
05/08/2019; 01/24/2019
Dividend USD 0.37
02/06/2019; 10/25/2018
Dividend USD 0.37
11/07/2018; 08/02/2018
Dividend USD 0.37
08/15/2018; 04/26/2018
Dividend USD 0.35
05/09/2018; 01/22/2018
Dividend USD 0.35
02/07/2018; 10/25/2017
Dividend USD 0.35
11/08/2017; 08/02/2017
Dividend USD 0.35
08/15/2017; 04/28/2017
Dividend USD 0.33
05/09/2017; 01/24/2017
Dividend USD 0.33
02/07/2017; 10/26/2016
Dividend USD 0.33
11/08/2016; 07/28/2016
Dividend USD 0.33
08/16/2016; 04/27/2016
Dividend USD 0.3
05/17/2016; 01/21/2016
Dividend USD 0.3
02/09/2016; 10/22/2015
Dividend USD 0.3
11/17/2015; 07/30/2015
Dividend USD 0.3
08/18/2015; 04/23/2015
Dividend USD 0.28
05/19/2015; 01/22/2015
Dividend USD 0.28
02/10/2015; 10/24/2014
Dividend USD 0.28
11/18/2014; 07/31/2014
Dividend USD 0.28
08/19/2014; 04/23/2014
Dividend USD 0.25
05/16/2014; 01/23/2014
Dividend USD 0.25
02/14/2014; 10/25/2013
Dividend USD 0.25
11/15/2013; 08/02/2013
Dividend USD 0.25
08/16/2013

All
Financials
Insiders

About RMD

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Webull offers kinds of ResMed Inc. stock information, including NYSE:RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.